Literature DB >> 30206117

How I manage medical complications of β-thalassemia in adults.

Ali T Taher1, Maria Domenica Cappellini2.   

Abstract

The complex pathophysiology in β-thalassemia can translate to multiple morbidities that affect every organ system. Improved survival due to advances in management means that patients are exposed to the harmful effects of ineffective erythropoiesis, anemia, and iron overload for a longer duration, and we started seeing new or more frequent complications in adult compared with younger patients. In this article, we highlight particular aspects of managing adult patients with β-thalassemia, using our own experience in treating such patients. We cover both transfusion-dependent and nontransfusion-dependent forms of the disease and tackle specific morbidities of highest interest.
© 2018 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2018        PMID: 30206117     DOI: 10.1182/blood-2018-06-818187

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  23 in total

1.  Frequency of thyroid nodules in patients with β-thalassemias in Southern Iran.

Authors:  S Haghpanah; P Pishdad; T Zarei; A Shahsavani; F Amirmoezi; H Ilkhanipoor; H Ilkhanipoor; S Safaei; F Setoodegan; V De Sanctis; M Karimi
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Jan-Mar       Impact factor: 0.877

Review 2.  A Short Review on Growth and Endocrine Long-term Complications in Children and Adolescents with β-Thalassemia Major: Conventional Treatment versus Hematopoietic Stem Cell Transplantation.

Authors:  Shayma Ahmed; Ashraf Soliman; Vincenzo De Sanctis; Nada Alaaraj; Fawzia Alyafei; Noor Hamed; Mohamed Yassin
Journal:  Acta Biomed       Date:  2022-08-31

Review 3.  Targeting the Hematopoietic Stem Cell Niche in β-Thalassemia and Sickle Cell Disease.

Authors:  Annamaria Aprile; Silvia Sighinolfi; Laura Raggi; Giuliana Ferrari
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-11

4.  Screening and diagnosis of hemoglobinopathies in Germany: Current state and future perspectives.

Authors:  Carmen Aramayo-Singelmann; Susan Halimeh; Pia Proske; Abinuja Vignalingarajah; Holger Cario; Morten O Christensen; Raina Yamamoto; Alexander Röth; Dirk Reinhardt; Hans Christian Reinhardt; Ferras Alashkar
Journal:  Sci Rep       Date:  2022-06-13       Impact factor: 4.996

Review 5.  Advancing the care of β-thalassaemia patients with novel therapies.

Authors:  Rayan Bou-Fakhredin; Irene Motta; Maria Domenica Cappellini
Journal:  Blood Transfus       Date:  2021-10-21       Impact factor: 3.443

6.  Prescribing patterns and drug-related problems (DRPs) in transfusion-dependent paediatric thalassemia patients: A prospective interventional study from a tertiary care hospital in India.

Authors:  Tirin Babu; George Mathew Panachiyil; Juny Sebastian; Mandyam Dhati Ravi
Journal:  Int J Pediatr Adolesc Med       Date:  2020-01-07

Review 7.  The European Medicines Agency Review of Luspatercept for the Treatment of Adult Patients With Transfusion-dependent Anemia Caused by Low-risk Myelodysplastic Syndromes With Ring Sideroblasts or Beta-thalassemia.

Authors:  Julio Delgado; Caroline Voltz; Milena Stain; Ewa Balkowiec-Iskra; Brigitte Mueller; Johanna Wernsperger; Iwona Malinowska; Christian Gisselbrecht; Harald Enzmann; Francesco Pignatti
Journal:  Hemasphere       Date:  2021-07-19

8.  Murine bone marrow mesenchymal stromal cells have reduced hematopoietic maintenance ability in sickle cell disease.

Authors:  Alice Tang; Ana Nicolle Strat; Mahmudur Rahman; Helen Zhang; Weili Bao; Yunfeng Liu; David Shi; Xiuli An; Deepa Manwani; Patricia Shi; Karina Yazdanbakhsh; Avital Mendelson
Journal:  Blood       Date:  2021-12-16       Impact factor: 25.476

9.  Hemolysis inhibits humoral B-cell responses and modulates alloimmunization risk in patients with sickle cell disease.

Authors:  Mouli Pal; Weili Bao; Rikang Wang; Yunfeng Liu; Xiuli An; William B Mitchell; Cheryl A Lobo; Caterina Minniti; Patricia A Shi; Deepa Manwani; Karina Yazdanbakhsh; Hui Zhong
Journal:  Blood       Date:  2021-01-14       Impact factor: 25.476

Review 10.  Hepatocellular carcinoma in adult thalassemia patients: an expert opinion based on current evidence.

Authors:  Alessandra Mangia; Davide Bellini; Umberto Cillo; Andrea Laghi; Giuseppe Pelle; Vanna Maria Valori; Eugenio Caturelli
Journal:  BMC Gastroenterol       Date:  2020-08-03       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.